Skip to main content
Download PDF

The role of TTE in assessment of the patient before and following TAVI for AS

Echo Research & Practice volume 3, pages R20–R34 (2016)Cite this article

References

  1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al., 2010 Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine 363 1597–1607. (doi:10.1056/NEJMoa1008232)

    CAS  PubMed  Google Scholar 

  2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al., 2011 Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine 364 2187–2198. (doi:10.1056/NEJMoa1103510)

    CAS  PubMed  Google Scholar 

  3. Ludman PF, Moat N, de Belder MA, Blackman DJ, Duncan A, Banya W, MacCarthy PA, Cunningham D, Wendler O, Marlee D, et al., 2015 Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation 131 1181–1190. (doi:10.1161/CIRCULATIONAHA.114.013947)

    PubMed  Google Scholar 

  4. The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial 2016 A multi-centre randomised controlled trial to assess the clinical effectiveness and cost utility of TAVI, compared with conventional surgical aortic valve replacement (AVR), in patients with severe symptomatic aortic stenosis at intermediate or high operative risk. UK Clinical Trials Gateway. Trial ID number: ISRCTN57819173. (available at: https://www.ukctg.nihr.ac.uk/trials/trial-details/trial-details?trialId=3826)

  5. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, et al., 2012 Guidelines on the management of valvular heart disease (version 2012). European Heart Journal 33 2451–2496. (doi:10.1093/eurheartj/ehs109)

    Google Scholar 

  6. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al., 2014 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 63 e57–e185. (doi:10.1016/j.jacc.2014.02.536)

    Article  PubMed  Google Scholar 

  7. Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, et al., 2011 Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 124 1964–1972. (doi:10.1161/CIRCULATIONAHA.111.040022)

    PubMed  Google Scholar 

  8. Eveborn GW, Schirmer H, Heggelund G, Lunde P & Rasmussen K 2013 The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart 99 396–400. (doi:10.1136/heartjnl-2012-302265)

    PubMed  Google Scholar 

  9. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M, et al., 2009 Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Journal of the American Society of Echocardiography 22 1–23. (doi:10.1016/j.echo.2008.11.029)

    PubMed  Google Scholar 

  10. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ & Jander N 2008 Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. European Heart Journal 29 1043–1048. (doi:10.1093/eurheartj/ehm543)

    PubMed  Google Scholar 

  11. Thaden JJ, Nkomo VT, Lee KJ & Oh JK 2015 Doppler imaging in aortic stenosis: the importance of the nonapical imaging windows to determine severity in a contemporary cohort. Journal of the American Society of Echocardiography 28 780–785. (doi:10.1016/j.echo.2015.02.016)

    PubMed  Google Scholar 

  12. Shiran A, Adawi S, Ganaeem M & Asmer E 2009 Accuracy and reproducibility of left ventricular outflow tract diameter measurement using transthoracic when compared with transesophageal echocardiography in systole and diastole. European Journal of Echocardiography 10 319–324. (doi:10.1093/ejechocard/jen254)

    PubMed  Google Scholar 

  13. Saitoh T, Shiota M, Izumo M, Gurudevan SV, Tolstrup K, Siegel RJ & Shiota T 2012 Comparison of left ventricular outflow geometry and aortic valve area in patients with aortic stenosis by 2-dimensional versus 3-dimensional echocardiography. American Journal of Cardiology 109 1626–1631. (doi:10.1016/j.amjcard.2012.01.391)

    PubMed  Google Scholar 

  14. Mehrotra P, Flynn AW, Jansen K, Tan TC, Mak G, Julien HM, Zeng X, Picard MH, Passeri JJ & Hung J 2015 Differential left ventricular outflow tract remodeling and dynamics in aortic stenosis. Journal of the American Society of Echocardiography 28 1259–1266. (doi:10.1016/j.echo.2015.07.018)

    PubMed  Google Scholar 

  15. Muraru D, Badano LP, Vannan M & Iliceto S 2012 Assessment of aortic valve complex by three-dimensional echocardiography: a framework for its effective application in clinical practice. European Heart Journal: Cardiovascular Imaging 13 541–555. (doi:10.1093/ehjci/jes075)

    PubMed  Google Scholar 

  16. Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, et al., 2014 Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. Heart 100 1946–1953. (doi:10.1136/heartjnl-2014-305763)

    PubMed  Google Scholar 

  17. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST & Holmes DR 2002 Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106 809–813. (doi:10.1161/01.CIR.0000025611.21140.34)

    PubMed  Google Scholar 

  18. Passeri JJ, Elmariah S, Xu K, Inglessis I, Baker JN, Alu M, Kodali S, Leon MB, Svensson LG, Pibarot P, et al., 2015 Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF. Heart 101 463–471. (doi:10.1136/heartjnl-2014-306737)

    PubMed  Google Scholar 

  19. Herrmann HC, Pibarot P, Hueter I, Gertz ZM, Stewart WJ, Kapadia S, Tuzcu EM, Babaliaros V, Thourani V, Szeto WY, et al., 2013 Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. Circulation 127 2316–2326. (doi:10.1161/CIRCULATIONAHA.112.001290)

    PubMed  Google Scholar 

  20. Quader N, Wilansky S, Click RL & Katayama M, Chaliki HP 2015 Visual estimation of the severity of aortic stenosis and the calcium burden by 2-dimensional echocardiography: is it reliable? Journal of Ultrasound in Medicine 34 1711–1717. (doi:10.7863/ultra.15.14.11045)

    PubMed  Google Scholar 

  21. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G & Baumgartner H 2000 Predictors of outcome in severe, asymptomatic aortic stenosis. New England Journal of Medicine 343 611–617. (doi:10.1056/NEJM200008313430903)

    CAS  PubMed  Google Scholar 

  22. Hachicha Z, Dumesnil JG, Bogaty P & Pibarot P 2007 Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 115 2856–2864. (doi:10.1161/CIRCULATIONAHA.106.668681)

    PubMed  Google Scholar 

  23. Mehrotra P, Jansen K, Flynn AW, Tan TC, Elmariah S, Picard MH & Hung J 2013 Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. European Heart Journal 34 1906–1914. (doi:10.1093/eurheartj/ehbib94)

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Hachicha Z, Dumesnil JG & Pibarot P 2009 Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. Journal of the American College of Cardiology 54 1003–1011. (doi:10.1016/j.jacc.2009.04.079)

    PubMed  Google Scholar 

  25. Herrmann S, Stork S, Niemann M, Lange V, Strotmann JM, Frantz S, Beer M, Gattenlohner S, Voelker W, Ertl G, et al., 2011 Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. Journal of the American College of Cardiology 58 402–412. (doi:10.1016/j.jacc.2011.02.059)

    PubMed  Google Scholar 

  26. Pibarot P, Dumesnil JG 2012 Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. Journal of the American College of Cardiology 60 1845–1853. (doi:10.1016/j.jacc.2012.06.051)

    PubMed  Google Scholar 

  27. Zilberszac R, Gabriel H, Schemper M, Zahler D, Czerny M, Maurer G & Rosenhek R 2013 Outcome of combined stenotic and regurgitant aortic valve disease. Journal of the American College of Cardiology 61 1489–1495. (doi:10.1016/j.jacc.2012.11.070)

    PubMed  Google Scholar 

  28. Hahn RT, Little SH, Monaghan MJ, Kodali SK, Williams M, Leon MB & Gillam LD 2015 Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR. JACC: Cardiovascular Imaging 8 261–287. (doi:10.1016/j.jcmg.2014.12.014)

    PubMed  Google Scholar 

  29. Mylotte D, Lefevre T, Sondergaard L, Watanabe Y, Modine T, Dvir D, Bosmans J, Tchetche D, Kornowski R, Sinning JM, et al., 2014 Transcatheter aortic valve replacement in bicuspid aortic valve disease. Journal of the American College of Cardiology 64 2330–2339. (doi:10.1016/j.jacc.2014.09.039)

    PubMed  Google Scholar 

  30. Khalique OK, Hahn RT, Gada H, Nazif TM, Vahl TP, George I, Kalesan B, Forster M, Williams MB, Leon MB, et al., 2014 Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC: Cardiovascular Interventions 7 885–894. (doi:10.1016/j.jcin.2014.03.007)

    PubMed  Google Scholar 

  31. Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia SR, Kodali S, Tamburino C, Barbanti M, Chakravarty T, Jilaihawi H, et al., 2013 Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. Journal of the American College of Cardiology 62 1552–1562. (doi:10.1016/j.jacc.2013.07.040)

    PubMed  Google Scholar 

  32. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG & Enriquez-Sarano M 2006 Burden of valvular heart diseases: a population-based study. Lancet 368 1005–1011. (doi:10.1016/S0140-6736(06)69208-8)

    PubMed  Google Scholar 

  33. Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochelliere R, Dumont E, Doyle D, DeLarochelliere H, Laflamme J, et al., 2014 Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. Journal of the American College of Cardiology 63 2643–2658. (doi:10.1016/j.jacc.2014.02.573)

    PubMed  Google Scholar 

  34. Harling L, Saso S, Jarral OA, Kourliouros A, Kidher E & Athanasiou T 2011 Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with? European Journal of Cardio-Thoracic Surgery 40 1087–1096. (doi:10.1016/j.ejcts.2011.03.036)

    PubMed  Google Scholar 

  35. Nombela-Franco L, Eltchaninoff H, Zahn R, Testa L, Leon MB, Trillo-Nouche R., D Onofrio A, Smith CR, Webb J, Bleiziffer S, et al. 2015 Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart 101 1395–1405. (doi:10.1136/heartjnl-2014-307120)

    CAS  PubMed  Google Scholar 

  36. Toggweiler S, Boone RH, Rodés-Cabau J, Humphries KH, Lee M, Nombela-Franco L, Bagur R, Willson AB, Binder RK, Gurvitch R, et al., 2012 Transcatheter aortic valve replacementoutcomes of patients with moderate or severe mitral regurgitation. Journal of the American College of Cardiology 59 2068–2074. (doi:10.1016/j.jacc.2012.02.020)

    PubMed  Google Scholar 

  37. Bedogni F, Latib A, Brambilla N, De Marco F, Oreglia J, Agnifili M, Pizzocri S, Lanotte S, Latini R, Petronio AS, et al., 2013 Interplay between mitral regurgitation and transcatheter aortic valve replacement with the corevalve revalving system: a multicenter registry. Circulation 128 2145–2153. (doi:10.1161/CIRCULATIONAHA.113.001822)

    PubMed  Google Scholar 

  38. Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni F, Rück A, Barbanti M, Toggweiler S, Thomas M, et al., 2015 Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. American Journal of Cardiology 115 942–949. (doi:10.1016/j.amjcard.2015.01.022)

    PubMed  Google Scholar 

  39. Tarantini G 2003 Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery. European Journal of Cardio-Thoracic Surgery 24 879–885. (doi:10.1016/S1010-7940(03)00575-X)

    PubMed  Google Scholar 

  40. Pai RG, Varadarajan P & Razzouk A 2008 Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. Annals of Thoracic Surgery 86 1781–1789. (doi:10.1016/j.athoracsur.2008.08.008)

    PubMed  Google Scholar 

  41. Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, et al., 2013 Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circulation: Cardiovascular Interventions 6 604–614. (doi:10.1161/CIRCINTERVENTIONS.113.000650)

    Google Scholar 

  42. Powell DE, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM, Perez JL & Kronzon I 2000 Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Archives of Internal Medicine 160 1337–1341. (doi:10.1001/archinte.160.9.1337)

    CAS  PubMed  Google Scholar 

  43. Kapoor N, Varadarajan P & Pai RG 2008 Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis. European Heart Journal: Cardiovascular Imaging 9 31–33.(doi:10.1016/j.euje.2007.01.005)

    Google Scholar 

  44. Malouf JF, Enriquez-Sarano M, Pellikka PA, Oh JK, Bailey KR, Chandrasekaran K, Mullany CJ & Tajik AJ 2002 Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. Journal of the American College of Cardiology 40 789–795. (doi:10.1016/S0735-1097(02)02002-8)

    PubMed  Google Scholar 

  45. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, et al., 2012 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. Journal of the American College of Cardiology 59 1200–1254.(doi:10.1016/j.jacc.2012.01.001)

    PubMed  Google Scholar 

  46. Luçon A, Oger E, Bedossa M, Boulmier D, Verhoye JP, Eltchaninoff H, Iung B, Leguerrier A, Laskar M, Leprince P, et al., 2014 Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the france 2 registry. Circulation: Cardiovascular Interventions 7 240–247. (doi:10.1161/CIRCINTERVENTIONS.113.000482)

    Google Scholar 

  47. Lindman BR, Zajarias A, Maniar HS, Miller DC, Suri RM, Arnold SV, Webb J, Svensson LG, Kodali S, Xu K, et al., 2015 Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. Heart 101 1656–1664. (doi:10.1136/heartjnl-2015-308001)

    CAS  PubMed  Google Scholar 

  48. Mascherbauer J, Kammerlander AA, Marzluf BA, Graf A, Kocher A & Bonderman D 2015 Prognostic impact of tricuspid regurgitation in patients undergoing aortic valve surgery for aortic stenosis. PLoS ONE 10 e0136024. (doi:10.1371/journal.pone.0136024)

    Google Scholar 

  49. Jeong DS, Sung K, Kim WS, Lee YT, Yang J-H, Jun T-G & Park PW 2013 Fate of functional tricuspid regurgitation in aortic stenosis after aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery 148 1328–1333. (doi:10.1016/j.jtcvs.2013.10.056)

    PubMed  Google Scholar 

  50. Barbanti M, Binder RK, Dvir D, Tan J, Freeman M, Thompson CR, Cheung A, Wood DA, Leipsic J & Webb JG, Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions 85 677-684. (oi:10.1002/ccd.25512)

  51. Lindman BR, Maniar HS, Jaber WA, Lerakis S, Mack MJ, Suri RM, Thourani VH, Babaliaros V, Kereiakes DJ, Whisenant B, et al., 2015 Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Circulation: Cardiovascular Interventions 8 e002073. (doi:10.1161/CIRCINTERVENTIONS.114.002073)

    Google Scholar 

  52. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK & Schiller NB 2010 Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal of the American Society of Echocardiography 23 685–713. (doi:10.1016/j.echo.2010.05.010)

    PubMed  Google Scholar 

  53. Smith LA & Monaghan MJ 2013 Monitoring of procedures: peri-interventional echo assessment for transcatheter aortic valve implantation. European Heart Journal of Cardiovascular Imaging 14 840–850. (doi:10.1093/ehjci/jebib42)

    Google Scholar 

  54. Durand E, Borz B, Godin M, Tron C, Litzler P-Y, Bessou J-P, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher J-N, et al., 2012 Transfemoral aortic valve replacement with the edwards sapien and edwards sapien xt prosthesis using exclusively local anesthesia and fluoroscopic guidancefeasibility and 30-day outcomes. JACC: Cardiovascular Interventions 5 461–467. (doi:10.1016/j.jcin.2012.01.018)

    PubMed  Google Scholar 

  55. Greif M, Lange P, Näbauer M, Schwarz F, Becker C, Schmitz C, Pohl T, D’Anastasi M, Boekstegers P, Massberg S, et al., 2014 Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart 100 691–695. (doi:10.1136/heartjnl-2013-304918)

    PubMed  Google Scholar 

  56. Dall’Ara G, Eltchaninoff H, Moat N, Laroche C, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, et al., 2014 Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation. International Journal of Cardiology 177 448–454. (doi:10.1016/j.ijcard.2014.09.025)

    PubMed  Google Scholar 

  57. Attizzani GF, Alkhalil A, Padaliya B, Tam C-C, Lopes JP, Fares A, Bezerra HG, Medallion B, Park S, Deo S, et al., 2015 Comparison of outcomes of transfemoral transcatheter aortic valve implantation using a minimally invasive versus conventional strategy. American Journal of Cardiology 116 1731–1736. (doi:10.1016/j.amjcard.2015.08.044)

    PubMed  Google Scholar 

  58. Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, et al., 2014 Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry. Circulation: Cardiovascular Interventions 7 602–610. (doi:10.1161/circinterventions.113.000403)

    Google Scholar 

  59. Hahn RT, Pibarot P, Weissman NJ, Rodriguez L & Jaber WA 2015 Assessment of paravalvular aortic regurgitation after transcatheter aortic valve replacement: intra–core laboratory variability. Journal of the American Society of Echocardiography 28 415–422. (doi:10.1016/j.echo.2015.01.007)

    PubMed  Google Scholar 

  60. Pibarot P, Hahn RT, Weissman NJ & Monaghan MJ 2015 Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. JACC: Cardiovascular Imaging 8 340–360. (doi:10.1016/j.jcmg.2015.01.008)

    PubMed  Google Scholar 

  61. Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, Jensen JM, Webb J, Blanke P, Tang M, et al., 2015 Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circulation: Cardiovascular Interventions 8 e001596. (doi:10.1161/CIRCINTERVENTIONS.114.001596)

    Google Scholar 

  62. Cordoba-Soriano JG, Puri R, Amat-Santos I, Ribeiro HB, Abdul-Jawad Altisent O, del Trigo M, Paradis JM, Dumont E, Urena M & Rodes-Cabau J 2015 Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Revista Española de Cardiología 68 198–204. (doi:10.1016/j.rec.2014.10.003)

    PubMed  Google Scholar 

  63. Clavel MA, Rodes-Cabau J, Dumont E, Bagur R, Bergeron S, De Larochelliere R, Doyle D, Larose E, Dumesnil JG & Pibarot P 2011 Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC: Cardiovascular Imaging 4 1053–1062. (doi:10.1016/j.jcmg.2011.06.021)

    PubMed  Google Scholar 

  64. Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ & Connolly HM 2015 Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. Journal of the American College of Cardiology 66 2285–2294. (doi:10.1016/j.jacc.2015.09.022)

    PubMed  Google Scholar 

  65. Ibebuogu UN, Giri S, Bolorunduro O, Tartara P, Kar S, Holmes D & Alli O 2015 Review of reported causes of device embolization following trans-catheter aortic valve implantation. American Journal of Cardiology 115 1767–1772. (doi:10.1016/j.amjcard.2015.03.024)

    PubMed  Google Scholar 

  66. Mylotte D, Andalib A, Theriault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, et al., 2015 Transcatheter heart valve failure: a systematic review. European Heart Journal 36 1306–1327. (doi:10.1093/eurheartj/ehu388)

    PubMed  Google Scholar 

  67. Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, Gutierrez-Ibanes E, Munoz-Garcia AJ, Pan M, Webb JG, et al., 2015 Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 131 1566–1574. (doi:10.1161/CIRCULATIONAHA.114.014089)

    PubMed  Google Scholar 

Download references

Funding

This work did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Author information

Authors and Affiliations

  1. University Hospital Birmingham NHS Foundation Trust & Institute of Cardiovascular Science, University of Birmingham, Edgbaston Birmingham, UK

    John Fryearson MBChB MRCP, Nicola C. Edwards PhD MRCP, Sagar N. Doshi MD FRCP & Richard P. Steeds MA MD FRCP FESC

Authors
  1. John Fryearson MBChB MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola C. Edwards PhD MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sagar N. Doshi MD FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard P. Steeds MA MD FRCP FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Fryearson MBChB MRCP.

Rights and permissions

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fryearson, J., Edwards, N.C., Doshi, S.N. et al. The role of TTE in assessment of the patient before and following TAVI for AS. Echo Res Pract 3, R20–R34 (2016). https://doi.org/10.1530/ERP-16-0004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-16-0004

Key Words

Echo Research & Practice

ISSN: 2055-0464

Contact us